These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 3554512)

  • 21. Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology Program.
    Ashby J; Tennant RW; Zeiger E; Stasiewicz S
    Mutat Res; 1989 Jun; 223(2):73-103. PubMed ID: 2662004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of the National Toxicology Program data on in vitro genetic toxicity tests using multivariate statistical methods.
    Benigni R
    Mutagenesis; 1989 Nov; 4(6):412-9. PubMed ID: 2695754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An approach to identifying specialized batteries of bioassays for specific classes of chemicals: class analysis using mutagenicity and carcinogenicity relationships and phylogenetic concordance and discordance patterns. 1. Composition and analysis of the overall data base. A report of phase II of the U.S. Environmental Protection Agency Gene-Tox Program.
    Ray VA; Kier LD; Kannan KL; Haas RT; Auletta AE; Wassom JS; Nesnow S; Waters MD
    Mutat Res; 1987 May; 185(3):197-241. PubMed ID: 3574331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmonella tester strains: mutational targets and correlation with animal carcinogenicity and teratogenicity.
    Hartman PE; Aukerman SL
    Basic Life Sci; 1986; 38():407-24. PubMed ID: 3527148
    [No Abstract]   [Full Text] [Related]  

  • 25. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NTP technical report on toxicity studies of t-butyl alcohol (CAS No. 75-65-0). Administered by inhalation to F344/N rats and B6C3F1 mice.
    Mahler J
    Toxic Rep Ser; 1997 Jul; (53):1-56, A1-D9. PubMed ID: 11803704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive assay for rodent carcinogenicity using in vivo biochemical parameters: operational characteristics and complementarity.
    Kitchin KT; Brown JL; Kulkarni AP
    Mutat Res; 1992 Apr; 266(2):253-72. PubMed ID: 1373835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An evaluation of the host-mediated assay and body fluid analysis. A report of the U.S. Environmental Protection Agency Gene-Tox Program.
    Legator MS; Bueding E; Batzinger R; Connor TH; Eisenstadt E; Farrow MG; Ficsor G; Hsie A; Seed J; Stafford RS
    Mutat Res; 1982 May; 98(3):319-74. PubMed ID: 7050697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationships between in vitro mutagenicity assays.
    Benigni R
    Mutagenesis; 1992 Sep; 7(5):335-41. PubMed ID: 1470028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Learning rules to predict rodent carcinogenicity of non-genotoxic chemicals.
    Lee Y; Buchanan BG; Mattison DM; Klopman G; Rosenkranz HS
    Mutat Res; 1995 May; 328(2):127-49. PubMed ID: 7739598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The unique role of rodents in the detection of possible human carcinogens and mutagens.
    Ashby J
    Mutat Res; 1983 Jun; 115(2):177-213. PubMed ID: 6343849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mouse spot test. Evaluation of its performance in identifying chemical mutagens and carcinogens.
    Styles JA; Penman MG
    Mutat Res; 1985 Nov; 154(3):183-204. PubMed ID: 3900714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How do in vivo mammalian assays compare to in vitro assays in their ability to detect mutagens?
    Natarajan AT; Obe G
    Mutat Res; 1986 May; 167(3):189-201. PubMed ID: 3083243
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutagenicity of urine and faeces after treatment of rats with known genotoxins.
    Willems MI; de Raat WK
    Carcinogenesis; 1985 Jul; 6(7):967-76. PubMed ID: 3893784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
    Kirkland D; Reeve L; Gatehouse D; Vanparys P
    Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term tests for mutagenesis and carcinogenesis in drug toxicology: how to test and when to test is the question.
    De La Iglesia FA; Lake RS; Fitzgerald JE
    Drug Metab Rev; 1980; 11(1):103-46. PubMed ID: 6448737
    [No Abstract]   [Full Text] [Related]  

  • 37. Statistical exploration of four major genotoxicity data bases: an overview.
    Benigni R; Giuliani A
    Environ Mol Mutagen; 1988; 12(1):75-83. PubMed ID: 3383841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantifying genotoxicity and non-genotoxicity.
    Rosenkranz HS; Ennever FK
    Mutat Res; 1988; 205(1-4):59-67. PubMed ID: 3285198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ability of short-term tests to predict carcinogenicity can be summarized in a single index.
    Benigni R
    J Toxicol Environ Health; 1991 Sep; 34(1):27-37. PubMed ID: 1890692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships among in vitro mutagenicity assays: quantitative vs. qualitative test results.
    Benigni R; Andreoli C; Giuliani A
    Environ Mol Mutagen; 1995; 26(2):155-62. PubMed ID: 7556112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.